Terms: = Liver cancer AND RET, RET51, 5979, P07949, ENSG00000165731, MTC1, MEN2A, RET-ELE1, HSCR1, MEN2B, CDHF12 AND Prognosis
18 results:
1. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
[TBL] [Abstract] [Full Text] [Related]
2. Establishment and Validation of Novel Prognostic Subtypes in Hepatocellular Carcinoma Based on Bile Acid Metabolism Gene Signatures Using Bulk and Single-Cell RNA-Seq Data.
Qu Y; Gong X; Zhao Z; Zhang Z; Zhang Q; Huang Y; Xie Q; Liu Y; Wei J; Du H
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255993
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive molecular analysis identifies ret alterations association with response of ICIs in multi-immunotherapy cohorts.
Long JY; Li RZ; Wang DX; Liu H; Tian J; Ding ZN; Yan LJ; Dong ZR; Hong JG; Tian BW; Han CL; Zhao HT; Li T
Int Immunopharmacol; 2024 Jan; 126():111281. PubMed ID: 38061115
[TBL] [Abstract] [Full Text] [Related]
4. [Chylous ascites in NSCLC: It is not always malignant].
Uhlenbruch M; Bärmann MK; Bertram V; Krüger S
Pneumologie; 2023 Dec; 77(12):1013-1015. PubMed ID: 37402387
[TBL] [Abstract] [Full Text] [Related]
5. Tumor-associated macrophage-derived GDNF promotes gastric cancer liver metastasis via a GFRA1-modulated autophagy flux.
Ni B; He X; Zhang Y; Wang Z; Dong Z; Xia X; Zhao G; Cao H; Zhu C; Li Q; Liu J; Chen H; Zhang Z
Cell Oncol (Dordr); 2023 Apr; 46(2):315-330. PubMed ID: 36808605
[TBL] [Abstract] [Full Text] [Related]
6. Hepatoid tumors of the gastrointestinal/pancreatobiliary district: morphology, immunohistochemistry, and molecular profiles.
Mattiolo P; Scarpa A; Luchini C
Hum Pathol; 2023 Feb; 132():169-175. PubMed ID: 35714834
[TBL] [Abstract] [Full Text] [Related]
7. Sorafenib in Metastatic Papillary Thyroid Carcinoma with
Caterino M; Pirozzi M; Facchini S; Zotta A; Sica A; Lo Giudice G; Rauso R; Varriale E; Ciardiello F; Fasano M
Medicina (Kaunas); 2022 May; 58(5):. PubMed ID: 35630083
[TBL] [Abstract] [Full Text] [Related]
8. A novel four-gene signature for predicting the prognosis of hepatocellular carcinoma.
Sun Y; Chen ZY; Gan X; Dai H; Cai D; Liu RH; Zhou JM; Zhang HL; Li ZH; Luo QQ; Jiang S; Wang T; Zhang KH
Scand J Gastroenterol; 2022 Oct; 57(10):1227-1237. PubMed ID: 35512233
[TBL] [Abstract] [Full Text] [Related]
9. Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment.
Wohlfeil SA; Häfele V; Dietsch B; Weller C; Sticht C; Jauch AS; Winkler M; Schmid CD; Irkens AL; Olsavszky A; Schledzewski K; Reiners-Koch PS; Goerdt S; Géraud C
J Transl Med; 2022 Feb; 20(1):62. PubMed ID: 35109875
[TBL] [Abstract] [Full Text] [Related]
10. Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo.
Spohr C; Poggio T; Andrieux G; Schönberger K; Cabezas-Wallscheid N; Boerries M; Halbach S; Illert AL; Brummer T
Leukemia; 2022 Apr; 36(4):970-982. PubMed ID: 34903841
[TBL] [Abstract] [Full Text] [Related]
11. Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study.
Bardet S; Goardon N; Lequesne J; Vaur D; Ciappuccini R; Leconte A; Monpeyssen H; Saguet-Rysanek V; Clarisse B; Lasne-Cardon A; Ménégaux F; Leenhardt L; Buffet C
Endocrine; 2021 Feb; 71(2):407-417. PubMed ID: 32638211
[TBL] [Abstract] [Full Text] [Related]
12. A 9‑lncRNA risk score system for predicting the prognosis of patients with hepatitis B virus‑positive hepatocellular carcinoma.
Liu H; Zhao P; Jin X; Zhao Y; Chen Y; Yan T; Wang J; Wu L; Sun Y
Mol Med Rep; 2019 Jul; 20(1):573-583. PubMed ID: 31115573
[TBL] [Abstract] [Full Text] [Related]
13. RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma.
Wang W; Jia WD; Hu B; Pan YY
Oncotarget; 2017 Apr; 8(16):26434-26447. PubMed ID: 28460436
[TBL] [Abstract] [Full Text] [Related]
14. TP53 and ret may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma.
Ye S; Zhao XY; Hu XG; Li T; Xu QR; Yang HM; Huang DS; Yang L
Oncol Rep; 2017 Apr; 37(4):2215-2226. PubMed ID: 28350084
[TBL] [Abstract] [Full Text] [Related]
15. Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through ret.
Sui C; Xu F; Shen W; Geng L; Xie F; Dai B; Lu J; Zhang M; Yang J
Tumour Biol; 2015 Mar; 36(3):1511-8. PubMed ID: 25374061
[TBL] [Abstract] [Full Text] [Related]
16. Medullary thyroid cancer: early detection and novel treatments.
Roman S; Mehta P; Sosa JA
Curr Opin Oncol; 2009 Jan; 21(1):5-10. PubMed ID: 19125012
[TBL] [Abstract] [Full Text] [Related]
17. MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?
Castellani MR; Seregni E; Maccauro M; Chiesa C; Aliberti G; Orunesu E; Bombardieri E
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):430-40. PubMed ID: 19088696
[TBL] [Abstract] [Full Text] [Related]
18. A case of multiple endocrine neoplasia type 2B.
Ohta M; Tokuda Y; Suzuki Y; Kuge S; Okumura A; Kubota M; Tajima T; Osamura RY; Mitomi T
Jpn J Clin Oncol; 1997 Aug; 27(4):268-73. PubMed ID: 9379517
[TBL] [Abstract] [Full Text] [Related]
